Pacific Biosciences of California (STU:P09) Net Change in Cash : €-115.2 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Pacific Biosciences of California's Net Change in Cash for the three months ended in Dec. 2024 was €-21.6 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was €-115.2 Mil.

Pacific Biosciences of California Net Change in Cash Historical Data

The historical data trend for Pacific Biosciences of California's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Net Change in Cash Chart

Pacific Biosciences of California Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

42.76

336.19

-129.81

-133.59

-119.41

Pacific Biosciences of California Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															-188.66	-95.00	20.83	-19.45	-21.60

Pacific Biosciences of California Net Change in Cash Calculation

Pacific Biosciences of California's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-196.785	+	118.424	+	-41.053	+	0
	=	-119.4

Pacific Biosciences of California's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -29.271 + 55.617 + -47.941 + 0

= -21.6

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-115.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Pacific Biosciences of California's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Biosciences of California Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Net Change in Cash

Comparable Companies

NNOX TCMD SMLR VREX NPCE VMD RCEL ZIMV CERS DCTH ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE

Traded in Other Exchanges

PACB:USA P09:Germany

Address

1305 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.pacb.com

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Pacific Biosciences of California Headlines

No Headlines